Actos (Pioglitazone) diabetes medication was introduced in August 1999. Since that time for the past 10 years there were conducted studies that have shown no proof that ACTOS drug is associated with an increase in risk of heart attack or stroke. As Pharmacoepidemiology and Drug Safety reported, nearly 30,000 patients were included in an observational [...]
It is generally known that in America more than 4.5 million people suffer from the most common complications of type 2 diabetes – congestive heart failure (CHF). CHF can be described as a condition when the heart cannot pump enough blood to the body’s other organs. In many cases it leads to fluid retention, or [...]
Today were presented the new findings in a late-breaker session at the World Congress of Cardiology in Barcelona. An oral antidiabetic medication ACTOS (pioglitazone HCl) was investigated and it was revealed that Actos drug significantly reduced the risk of recurrent stroke in high-risk patients with type 2 diabetes. Nowadays patients with diabetes are at an [...]
Antipsychotic medicine Risperdal (Risperidone) is indicated for the treatment of schizophrenia disease that is characterized by hallucinations, delusions and social withdrawal and for the short term treatment of bipolar manic depression, from what more than three million Americans believed to suffer. It has been known that physicians now have expanded two additional dosages (3 mg [...]
Seroquel medication is an approved medicine for bipolar disorder and schizophrenia medication. However, Seroquel drug is not approved for treatment of patients with dementia-related psychosis. Since its approval in 1997, SEROQUEL has had over 8 million patient exposures worldwide. The results of a safety investigation, which assessed the risk of cerebrovascular adverse events (CVAEs) in [...]
